Home › Stocks › SCNI › Changes

Who bought & sold SCNI (Q3 2026)

Funds holding (Q3 2026)6
New positions2
Added1
Reduced3
Exited6

As of Q3 2026, 6 institutional funds reported holding SCNI (SCINAI IMMUNOTHERAPEUTICS LT): 2 opened new positions, 1 added, 3 trimmed and 6 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.

New positions (2)

Fund Shares Value Weight
JPMorgan Chase & Co New 2 $3 —
DANSKE BANK A/S New 1 $1 —

Added to positions (1)

Fund Shares Value Weight Change
HRT FINANCIAL LP 31.62K $44.00K — +19.54K sh (+161.6%)

Reduced positions (3)

Fund Shares Value Weight Change
Citadel Advisors 20.76K $29.48K — -41.50K sh (-66.7%)
RHUMBLINE ADVISERS 1.35K $1.91K — -12.16K sh (-90.0%)
Morgan Stanley 5 $7 — -53 sh (-91.4%)

Exited positions (6)

Held in the prior quarter but not reported in the latest filing.

Fund Shares Value Weight
ARMISTICE CAPITAL, LLC Exited 35.94K $9.08K —
Virtu Financial LLC Exited 19.48K $5.00K —
StoneX Group Inc. Exited 13.09K $4.56K —
XTX Topco Ltd Exited 16.76K $4.24K —
CAPTRUST FINANCIAL ADVISORS Exited 12.04K $3.04K —
UBS Group AG Exited 3.96K $1.00K —